Dentsply Sirona Appoints John Fortson as Chief Financial Officer
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses John Fortson, Chief...
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses John Fortson, Chief...
BOSTON, June 11, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused...
Kennewick, WA, June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™...
Phase 2a study will evaluate the safety and biological activity of leronlimab in patients over the age of 50 with...
Pooled Phase 1/2 data show 80% complete remission rate in pediatric R/R T-ALL/LBL patients Global TENACITY-01 study reports 86% overall...
Management Believes the Company is Entering a Transformative Stage with a Novel, First-In-Class Cancer Therapy for Treatment & Prevention of...
Largest Sporting Event in History Expected to Bring Millions of Travelers Across Three Countries, Highlighting Growing Need for Advanced Large-Scale...
PET-CT imaging, Rather than CT Alone, Presented a Meaningful Reduction in Tumor Metabolic Activity After Treatment, Suggesting that PET May...
License allows the Company to commence large-scale extraction of castanospermine from the seeds of Castanospermum australe Company will meet with FDA...
– 12-month OS rate 94% among NPM1-m AML patients and 71% among KMT2A-r AML patients in single-arm KOMET-007 trial –...
– Prolonged overall survival (OS) was observed in heavily pre-treated refractory Head & Neck Squamous Cell Carcinoma (HNSCC) patients administered...
Flyte to expand private aviation demand, increase aircraft utilization, and accelerate revenue growthFlyte Gains Access to Fast-Growing Private Aviation Membership...
The clearance combines OraSure’s Colli-Pee™•Dx Urine Collection Kit for at-home sample collection with Roche’s cobas® molecular lab testing equipmentBETHLEHEM, Pa.,...
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18)...
Academic Medical Center Integrates Lifestyle Medicine, Behavioral Health, and Longitudinal Care Tech-Enabled Services into Primary Care Workflows with Research Initiative...
16 patients enrolled to date in trial of LTI-03 in idiopathic pulmonary fibrosis (IPF)First patient randomized in the United KingdomClinical...
Findings from 13 different studies analyzing 730 subjects to date in 2026 across multiple geographies underscore utility of OGM in...
PMA supplement under FDA review with potential approval in H2 2026, potentially expanding the Company’s addressable market to include TCAR...
Global pivotal Phase 3 trial will evaluate efficacy and safety of atebimetinib + modified gemcitabine/nab-paclitaxel (mGnP) compared to standard GnP...
Cebranopadol is an investigational, first-in-class dual-NMR agonist in development for acute and chronic pain as well as opioid use disorderFive...